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Abstract
Executive function and attention are highly complex cognitive constructs that typically reveal evidence of impairment in
people with schizophrenia. Studies in this area have traditionally utilised abstract tests of cognitive function and the
importance of using more ecologically valid tests has not been extensively recognised. In addition, there has been little
previous examination of the relationship between these key cognitive abilities and social functioning and quality of life in this
population. Thirty-six schizophrenic patients and 15 controls were assessed on the Behavioural Assessment of the
Dysexecutive Syndrome (BADS) test, three subtests from the Test of Everyday Attention (TEA), a measure of social
functioning and a quality of life measure. Analysis of subtest scores revealed that patients were impaired on all attentional
measures, but only one BADS subtest score in addition to the BADS profile score. However, 23 patients demonstrated no
impairment in their BADS profile scores whilst being impaired on at least one attentional measure. Only the BADS profile
score predicted social functioning and quality of life in schizophrenic patients. We conclude that ecologically valid tests of
attention and executive function can play an important role in defining the cognitive deficits in schizophrenia and how such
deficits relate to social function and quality of life.
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Introduction
Both executive function and attention are multi-
dimensional and highly complex cognitive con-
structs. The high-level guiding and organizing
nature of these processes means that both are often
required for the successful operation of other cogni-
tive domains, e.g., memory; and although they are
regarded as being intimately related to each other,
executive deficits are thought to affect the ability to
co-ordinate and guide processes that might otherwise
be regarded as attentional. For example, when
defining executive processes, some refer to the fact
that they guide attention as well as other processes
(e.g., memory), are involved in the planning, sequen-
cing and initiation of behaviour, self-monitoring, and
the inhibition of behaviour that is inconsistent with a
specific goal [1,2]. In some research, the two con-
structs are used almost interchangeably (e.g., [3]).
Indeed, both processes are considered to be mediated
by a supervisory attentional system (SAS [4]) which
plays an important role in the modulation of beha-
viour when tasks are novel, difficult and require a
degree of planning and forethought (see [5]).
The notion that deficits of both executive and
attentional function occur in schizophrenia can be
traced back to the seminal works of Bleuler [6] and
Kraepelin [7]. Indeed, cognitive fragmentation, lack
of co-ordination and integration of higher mental
functions figured prominently in their work; as did
references to ‘‘a certain unsteadiness of attention’’
[7], or that ‘‘acute attention was lacking’’ [6]. More
recently, poor performance on cognitive tasks
have been widely documented in people with schizo-
phrenia where mean effect sizes for both executive
function and attention have been large (for meta-
analytic reviews, see [810]; and even the relatives of
people with schizophrenia show small to medium
effect sizes [11]). Executive function (like attention),
of course, comprises a variety of abilities and has
been examined using a large number of tasks as
varied as the Wisconsin Card Sorting Test (WCST)
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through to verbal fluency and the Stroop (see [8] for
a review); some of which also (implicitly) seem to be
identified as tests of attention or minimally, as
demanding significant aspects of attention (e.g., the
Stroop and selective attention; the WCST and
attentional switching). Therefore, like attention,
executive function may be measured in a variety of
ways and like attention, no single test can cover the
manifold character of executive function. For exam-
ple, tests of switching or set-shifting attention are
typically regarded as tests of executive rather than
attentional function (e.g., [12]). Indeed, deficits in
this executive ability have been widely reported
in schizophrenia using a variety of experimental
paradigms that tap attentional function, including;
cross-modal switching [13], the Wisconsin Card
Sorting Test [1416], the symbol digit modalities
test (SDMT [17]) and the Intra/Extra dimensional
shift test (ID/ED [18,19]).
On a cognitive level, contemporary definitions of
attention suggest that this is a multifaceted concept
incorporating selective, sustained and divided com-
ponents [1]. Selective attention refers to the ability to
maintain focus on relevant stimuli or ideas in the
presence of other distracting stimuli and has com-
monly been found to be impaired in schizophrenic
patients on tasks such as the Stroop (e.g.,
[14,17,20,21]), Go/NoGo tasks (e.g., [22]) or in
paradigms where patients have to selectively respond
to auditory or visual stimuli (e.g., [23]). Sustained
attention (or vigilance) describes the ability to main-
tain attention and has been found to be impaired in
people with schizophrenia in a variety of paradigms,
including the Continuous Performance Test (CPT
[14,24,25]); the Digit Vigilance Test (DVT [17]),
and the Rapid Visual Information Processing Test
(RVP [18,26]). Divided attention refers to the ability
to attend simultaneously to more than one task or to
several elements within a task. Performance decre-
ments between individual and simultaneous task
trials provide an indication of the divided attention
abilities of patients. This aspect of attention has not
been extensively investigated in schizophrenia,
although the few studies that have been conducted
have reported impaired performance in schizophre-
nic patients relative to controls on tasks of counting
backwards whilst performing a visual digit cancella-
tion task [27] and on binary (auditory and visual)
choice reaction time tests [28].
Although many studies over several decades have
examined executive and attentional functioning in
people with schizophrenia, it should be noted that
many executive and attention tasks are quite abstract
in character (the paradigmatic case being the
WCST). Although both Card Sorting and measures
of vigilance relate to functional outcome [29], it is
important to examine these cognitive domains using
tasks that have some ecological validity. Ecological
validity has been described as the ‘‘functional and
predictive relationship between the patient’s perfor-
mance on a set of neuropsychological tests and the
patient’s behavior in a variety of real world settings’’
(Ref. [30] p. 16). Tasks that tap everyday experi-
ences (e.g., shopping, following a map, reading a
telephone directory) are more likely to overcome any
inherent motivational problems in schizophrenic
patients, especially on complex and demanding
executive and attentional tasks. Additionally, one
must consider the fact that traditional executive
tasks (in particular) are highly demanding and often
correlate strongly with measures of general intellec-
tual functioning (e.g., [8]). People with schizophre-
nia often present with an apparent IQ decline from
estimated premorbid levels and in many cases, their
schooling is severely interrupted. These factors
mean that highly complex and demanding tasks
may simply be pitched at too high a level to engage
schizophrenic patients. Fortunately, suitable ecolo-
gically valid batteries of attentional and executive
processes do exist in the form of the Everyday Test of
Attention (TEA [31]) and the Behavioural Assess-
ment of the Dysexecutive Syndrome (BADS [32]),
respectively; and these are used in the current study.
Although the TEA and the BADS have been well
validated in groups of brain-impaired patients, these
tests differ from traditional tests of attention and
executive function insofar as their focus is on
identifying individuals with limited functional abil-
ities rather than the discrimination of brain injured
and intact subjects; or in determining the etiology of
possible brain dysfunction [33]. Chaytor and
Schmitter-Edgecombe [33] have proposed that eco-
logical validity is established through verisimilitude
and veridicality. The former is the degree to which a
test appears similar to situations in daily life, while
the latter refers to the empirical relationship between
test performance and functioning in daily life. In this
context, the TEA and the BADS have high verisi-
militude. The importance of using ecologically valid
tests is stressed by studies which fail to find
consistent associations between social abilities
and performance on traditional, experimentally
based tests of cognitive function (e.g., [29,34,35]).
The current study examines the extent to which
people with schizophrenia are impaired on batteries
assessing ecologically valid (or everyday) attentional
(TEA) and executive (BADS) abilities. Further-
more, in studies such as this it is important to
incorporate an ecologically relevant criterion variable
to explore the extent that performance on the TEA
and BADS predicts social functioning in the com-
munity. Therefore patients will also be assessed with
a measure of social ability and community based
quality of life.
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
2 P.J. Tyson et al.
C:/3B2WIN/temp files/MPCP268579_S100.3d[x] Tuesday, 16th October 2007 17:46:58
UN
CO
RR
EC
TE
D P
RO
OF
Method
Patients
Thirty-six patients (31 males; five females) were
recruited from inpatient (N5) and outpatient
(N31) units in East Yorkshire, UK. These patients
all had a DSM-IV diagnosis of schizophrenia and no
history of neurological disease, head injury, sub-
stance or alcohol abuse. The patient sample had an
average age of 38 years (SD8; range 2252), and
had been ill for an average of 13 years (SD7 years;
range 2 months to 31 years). The Brief Psychiatric
Scale (BPRS) was used to assess symptom type and
severity [36] and the mean total score on this scale
was 10.6 (SD4.9; range 322). In addition, the
BPRS score was broken down according to the four
symptom dimensions identified by Overall et al. [37]
and subsequent ratings were: thinking disturbance
(M 4.1, SD 2.9, range 011); withdrawal/retarda-
tion (M 2.0, SD 2.0, range 08); hostility/suspi-
ciousness (M1.8. SD 1.4, range 05), and anxiety/
depression (M 4.6, SD 3.0, range 012).
To investigate associations between medication
levels and performance on the test battery, antipsy-
chotic dosages were converted to the Percentage of
Maximum Dose (PMD) in line with the British
National Formulary (BNF [38]). This method of
comparing antipsychotic potency circumvents some
of the problems of using chlorpromazine equivalents
as a method of assessing dose equivalence [39].
Controls
Fifteen non-psychiatric controls were drawn from
non-academic staff at the University of Hull and
nursing staff from local NHS services. They were
matched with the patient group for age (40.6 vs.
38.7: t490.72, P0.47) and estimated premor-
bid IQ (103.2 vs. 98.2: t491.22, P0.22) as
measured by the National Adult Reading test
(NART [40]).
Tests and procedure
Measures of attention and executive function
The Test of Everyday Attention (TEA [31]). Three
subtests were chosen from this battery in order to
investigate the key components of attention in an
ecologically valid paradigm:
1. Sustained attention. This refers to the ability to
sustain attention to repetitive stimuli. The TEA
sub-test is based on a scenario where subjects
are asked to imagine they are in an elevator with
no visual means of indicating which floor they
are on. Instead, the elevator ‘‘bleeps’’ whenever
it passes a floor and the subjects simply have to
count the bleeps in order to determine which
floor they have reached. Performance is judged
on how many sequences of bleeps the subject
counts correctly (up to 7).
2. Selective attention. This refers to the ability to
attend to target stimuli in the presence of
powerful distracters. This is similar to the
sustained attention task, although the subject
has to count bleeps of a certain pitch whilst
ignoring those of a different pitch. Performance
is judged on the number of sequences of bleeps
counted correctly (up to 10).
3. Divided attention. This concerns the ability to
respond to more than one task at the same time.
This TEA sub-test involves an auditory count-
ing task as detailed in the sustained attention
test and at the same time, the subject has to
search through a page from a telephone direc-
tory for specific entries. Performance is in terms
of the decrement in performance between
doing each task individually and both tasks
simultaneously.
The Behavioural Assessment of the Dysexecutive
Syndrome (BADS [32]). This battery contains six
subtests:
1. The Rule Shifts Cards Test in which a previously
established response set (responding ‘‘yes’’ to
red cards, ‘‘no’’ to black) has to be inhibited in
favour of responding in terms of whether or not
a card matches the colour of the card immedi-
ately preceding it. Time taken and errors made
constitute the performance indicators.
2. The Action Program Test is a planning task in
which the solution requires the client to utilize
various everyday materials (e.g., plastic, cork,
and wire) in order to solve a problem. Scoring
is based on the number of steps completed
without prompting.
3. The Key Search task requires subjects to imagine
they had lost their keys in a large field and are
required to draw the route they would use to
search for the keys. Scoring is based on the
search strategy and time taken.
4. The Temporal Judgement task requires subjects to
estimate the length of time it takes to perform
an everyday activity. Performance is judged in
terms of reasonable estimations according to
BADS norms.
5. The Zoo Map test requires subjects to plan a
route around a zoo in order to visit specific
animals whilst not breaking certain rules (e.g.,
not using some paths more than once). Key
performance indicators are the number of
errors made, the number of places visited in
the correct sequence, the time taken to plan the
route and the time taken to execute the plan.
6. The Modified Six Elements Test (see [41])
assesses scheduling and time management by
requiring clients to tackle three different tasks
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within the time limit; there are two versions of
each task and the rules prohibit tackling these
contiguously. Scoring is in terms of the number
of tasks attempted, the number of times a rule is
broken and the time spent on each activity
Measures of social function and quality of life
The Multinomah Community Ability Scale [42]. The
purpose of this Likert scale is to provide an indica-
tion of the level of social functioning of chronically
mentally ill patients living in the community. It is
designed to be completed by someone with a
detailed knowledge of the patient and poses ques-
tions about a number of different domains of social
function. An abridged version of the scale was used
in the current study, including the modules adjust-
ment to living and social competence.
The Quality of Life Self Assessment Inventory [43].
This is a self report scale which provides patients with
an opportunity to indicate areas of their life which
they deem as unsatisfactory. It contains a 100-item
inventory which is divided into 11 domains: housing,
environment, knowledge and education, contacts,
dependence, inner experiences, mental health; phy-
sical health, leisure, work and religion. The more
items that are deemed unsatisfactory, the lower the
quality of life.
Statistical analysis
Analysis of the frequency distributions of the TEA
and BADS scales in the control group, using the
D’AgostinoPearson omnibus test for normality
[44], revealed for three scales (i.e. TEA sustained
attention, BADS Action program, BADS Rule shift
card) non-normal distributions (K216.48, 38.41
and 17.71, respectively; all PB0.001). The patient
group also showed distributions that were non-
normal on exactly the same tests (K222.6, 19.79
and 10.21, respectively; all PB0.001). Because of
the distribution problems on these three tests, we
compared the groups using bootstrapping techni-
ques. Bootstrap methods require far fewer assump-
tions than traditional parametric tests regarding data
distributions and are advisable in circumstances
where controls score very highly or patients very
lowly [45]. With bootstrap techniques, a relevant test
statistic (t, F, r, etc.) is chosen and then computed
for the n bootstrap samples, i.e. n permutations of
the original group data. When this occurs with
replacement, a data point goes back into the sampling
pool and may be redrawn numerous times. After
many permutations, this results in a distribution of
test statistics (rather than data points). The value of
the original statistic is then compared to this new
distribution to determine whether it is abnormal,
e.g., if it is among the most extreme 5% of cases.
Hence bootstrap methods may be applied to data
collected using traditional stimuli (even when ceiling
effects are present). We created 1000 bootstrap
samples, each equal in size to the original sample,
by randomly resampling with replacement from the
original patient data. Initially we examined the 1000
resamples using independent t-tests to compare
patients and controls. The tests were performed
one-tailed, and power calculations showed that the
power for the t-test to detect a mean difference
between controls and patients amounting to a
medium effect size (Cohen’s d0.5) was b0.48
with an a error of 5% (one-tailed), and for a large
effect size (Cohen’s d0.8) the power was b0.82.
We also used bootstrap techniques to create 1000
Spearman’s rank correlation samples to investigate
the relation between TEA and BADS performance
scores and symptom ratings (BPRS), medication
(percent of maximum dose) and length of illness.
Finally, we created 1000 multiple regressions to
examine which measures of attention and executive
function predicted social functioning and quality of
life in the patients.
Results
Group comparison
The results of the between-group comparisons are
displayed in Table I. As expected, controls per-
formed significantly better on the selective, sustained
and divided attention tests, with moderate-large
effects size. Significant differences were only ob-
tained for one of five BADS tests (Rule Shift,) all of
which corresponded to medium effects sizes. How-
ever, a highly significant mean difference amounting
to a strong effect size was revealed for the BADS
total score (see Table I).
Finally, as Chapman and Chapman [44] have
pointed out, a differential deficit in performance
does not necessarily indicate a differential deficit in
ability. To measure differential deficit in ability,
tests must be matched on psychometric character-
istics of test reliability and test difficulty. In addi-
tion, differential discriminating power of the various
tasks may obscure any differential deficits in ability.
One problem with executive tests is that their
reliability is potentially invalid (largely because the
tests constitute an all or nothing process, i.e. the
tests measure executive function until their basis is
understood and then essentially become measures
of memory). Therefore, methods based on relia-
bility are not appropriate; however Chapman and
Chapman [45] presented an alternative using stan-
dardized residual scores. In the current study, we
used the BADS Profile score as a predictor for
performance on the three attentional tasks using the
control data to derive a regression equation. This
was used to predict patient performance; and then
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the standardized residual were calculated for each
of the three attention variables. We then compared
patients and controls on the standardized residual
measures. This revealed a significantly poorer
performance in the patients for: sustained (F
4.9, P0.031) and divided attention (F11.78,
PB0.001), but selective attention failed to reach
significance (F3.6, p0.070). Hence the degree
of impairment on sustained and divided attention
tasks was differentially greater than for the BADS
task.
Relationship between medication, symptoms and test
performance in patients
For patients, we examined the relationship of atten-
tion and executive test performance with symptom
ratings (BPRS), medication (percent of maximum
dose) and length of illness. All correlations were
weak (rsB0.30) and non-significant. Quality of Life
was significantly positively correlated with BPRS
scores and the percentage of maximum dose of
antipsychotics. By contrast, the social functioning
scores (Multinomah) correlated significantly with
the three attentional measures and the BADS profile
score (Table II).
Relationship between social function, quality of life and
test performance in patients
We ran hierarchical regression analyses on the
patient data blocking the three attentional variables
(sustained attention, selective attention, divided
attention), followed by the BADS profile score as
predictors of scores for social functioning (Multi-
nomah) and Quality of Life. For the Multinomah
questionnaire (social functioning) the multiple r2 was
0.33, P 0.01. The attentional measures were
nonsignificant (F1.67, P0.19); however, the
inclusion of BADS profile score in block two
approached significance (F3.65, P0.06). The
r2 change for the BADS was showed that it accounted
for 8% of the variance in the social functioning
measure. For the Quality of Life questionnaire the
multiple r2 was 0.20, P 0.13. The attentional
measures were nonsignificant (F1.02, P0.40);
however, again, the inclusion of BADS profile score
in block two approached significance (F3.75,
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Table I. Performance of schizophrenic patients and healthy controls on everyday measures of attention and executive function.
Test
Schizophrenic
patients n36
Healthy controls
n15 Mean P value*
Effect size
Cohen’s d (95% CI)*
Attention tests (TEA) M (SD) M (SD)
(Scaled scores)
Sustained attention 5.9 (1.6) 6.9 (0.3) .011 .59 (.90 to .35)
(Elevator counting)
Selective attention 5.2 (3.0) 7.9 (3.9) .048 .71 (1.5 to .10)
(Elevator counting with distraction)
Divided attention 4.9 (3.9) 9.7 (5.1) .010 1.1 (1.7 to .44)
(Telephone search whilst counting)
Executive Tests (BADS)
(Profile scores)
BADS Rule shift cards 3.2 (0.8) 3.7 (0.5) .028 .66 (1.2 to .21)
BADS Action program 3.4 (1.0) 3.9 (0.5) .070 .46 (.79 to .05)
BADS Key Search 2.3 (1.2) 2.6 (1.2) .210 .23 (.79 to .32)
BADS Temporal judgment 1.9 (0.9) 2.4 (1.1) .110 .51 (1.2 to .08)
BADS Zoo map 1.6 (1.1) 1.9 (1.2) .190 .28 (.89 to .31)
BADS Modified six elements 3.0 (1.1) 3.5 (0.8) .090 .49 (.98 to .04)
BADS total score 15.4 (3.4) 18.0 (2.4) .013 .79 (1.4 to .33)
*Derived from 1000 bootstrap independent t-tests.
Table II. Correlation matrix for background, cognitive and outcome measures.
% max BPRS Sus Sel Div BADS Multin Quality
Length of illness 0.08 0.22 0.01 0.07 0.10 0.18 0.05 0.20
Percent Max dose 0.16 0.13 0.12 0.05 0.28 0.07 0.36*
BPRS total 0.29 0.06 0.15 0.05 0.16 0.42*
Sustained 0.36* 0.31 0.44** 0.34* 0.02
Selective 0.69** 0.31 0.34* 0.03
Divided 0.33* 0.45** 0.21
BADS 0.47** 0.32
Multin 0.21
*PB0.05, **PB0.01.
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P0.06). The r2 change for the BADS showed that it
accounted for 10% of the variance in the Quality of
Life measure.
Incidence of impaired patients according to test norms
Using the norms for each test, we determined the
proportion of patients scoring below the 5th percen-
tile (according to age based comparisons). The
normative sample for each battery is large: for the
BADS, the normative sample comes from 216
healthy subjects and for the TEA, 154 healthy
subjects.
Patient scores were compared against the age-
based norms and divided into those above and below
the 5th percentile score for the normative sample.
This revealed that far more patients were intact than
impaired on the BADS total score (32 vs. 4) and the
sustained attention test (22 vs. 14); however, for the
selective (16 vs. 20) and divided attention measures
(12 vs. 24), the majority of patients were impaired
(see Figure 1). All four patients with impaired BADS
performance have at least one attentional impair-
ment; by contrast, 23 patients showed impairment
on at least one attention task and no overall BADS
impairment.
Discussion
The three TEA scores revealed evidence of atten-
tional impairment, with moderate to large effect sizes
in schizophrenic patients. By contrast, only the
overall BADS total profile and the rule shift subscale
scores revealed evidence of executive impairment
(with moderate effect sizes). The incidence and
degree of impairment differed across the executive
and attentional domains, with the latter revealing a
greater incidence and severity of impairment. The
standardised residual analysis shows that the differ-
ential deficits in performance are not due to psycho-
metric characteristics of the tests (e.g., test
difficulty). Indeed, the majority of patients displayed
some form of attentional deficit in the absence of any
executive dysfunction; and the small number of
patients with executive deficits all had attentional
deficits. Neither executive nor attentional perfor-
mance was related to the background variables of
symptom ratings, medication (percentage of max-
imum dose) or duration of illness. This suggests that
the presence of these cognitive deficits may be stable
parts of the profile of schizophrenia rather than
related to transient factors (relating, for example, to
symptoms, medication, or length of illness); and in
particular, that the severe and widespread atten-
tional problem cannot be attributed to such factors.
Our findings show that, unlike the attentional
measures, the BADS profile score predicts some
variance in the outcome measures (social function-
ing and quality of life: 8 and 10%, respectively) in
this patient group. These findings are consistent with
the wider literature of associations between neuro-
cognitive ability and social function [29] and a recent
study has found that the BADS in particular was a
significant predictor of functional outcome in this
patient group [46], although the association has not
been clearly shown in all studies [47]. Furthermore,
Ritsner [48] found that cognitive deficits predicted
impairments in quality of life in chronic schizophre-
nics, consistent with our results, Certainly, a wealth
of evidence now exists to emphasise the importance
of cognitive function to the social well-being of
people with schizophrenia.
Although executive dysfunction has been perva-
sively documented in studies, the BADS identified
only a minority of impaired patients in the current
study, i.e. scoring below the 5th percentile. Given
claims for the presence and pervasiveness of execu-
tive dysfunction or even frontal lobe disorder in
schizophrenia, our data indicate that such impair-
ments are perhaps neither as severe nor as wide-
spread as previously thought. The largest executive
deficit emerged for the overall profile score and this
is consistent with two recent studies that used the
full battery [49,50]. The profile score does, of
course, compound the six subtest differences; and
the patients performed significantly worse than
controls only on the rule shift task. Even on the
overall BADS profile measure, approximately only
10% of the patients scored within the impaired
range. There are several possible interpretations of
this finding. One is that the BADS battery is not
sensitive to executive dysfunction or the kinds of
executive dysfunction that are more commonly
demonstrated using other (more abstract) tests
such as the WCST, the Tower of London and so
on. Although, as noted earlier, such tests may be too
demanding for schizophrenic patients. Another pos-
sible interpretation is that the everyday character of
the battery in some way makes it easier for the
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patients to complete. Indeed, as hoped, patients may
be able to draw on their life experience when
attempting the BADS tasks and this might compen-
sate for even moderate executive dysfunction. This
notion is consistent with BADS having high verisi-
militude, and our findings that this battery predicts
social functioning also supports this assertion.
Nevertheless, some authors propose that the BADS
may be sensitive to subtle executive deficits that are
not identified by some more traditional test of
executive function [51]. It is also worth noting that
ecologically valid tests of executive function rely on
multiple cognitive domains and may not purely
index the hypothesized cognitive constructs, e.g.,
the Action Program test of the BADS requires
planning, self monitoring and inhibition.
The low level of executive impairment reported
here, and the fact that many patients with attentional
deficit showed no executive problems, suggests that
attentional problems are not only more common and
more severe, but may occur independently of execu-
tive dysfunction in schizophrenia. This accords with
evidence from longitudinal high-risk studies in off-
spring of parents with schizophrenia, which suggest
that abnormalities in attention are present far before
the onset of the illness [52,53]. It is important to
note that we did not find that patients performance
on the attentional tasks to be predictors of social
function or quality of life. This finding is not
consistent with the wider literature, e.g., [29,48].
Perhaps the ecological validity (and verisimilitude) of
the attentional tasks chosen can be questioned
(indeed the authors do not consider ‘‘counting
bleeps’’ to be a very common pastime in everyday
life). It is also plausible that the cognitive concept of
attention is not as closely related to social function as
executive function. Furthermore, it has been sug-
gested in the literature that cognitive abilities have to
be at a certain criterion level in order to demonstrate
an association with social abilities [54]. Therefore
patient’s performance on the attentional tasks did
not meet this criterion threshold, yet performance on
the executive tasks did.
The deficit of attention identified here affected all
three aspects of attention that were measured.
Nonetheless, our data indicate that not all aspects
of attention were comparably impaired in schizo-
phrenic patients, but that divided attention seemed
most sensitive, while sustained was the least im-
paired and selective fell between the two. As detailed
in the introduction, deficits in these aspects of
attention have been previously reported in the
literature, although as far as we are aware, this study
is the first to document such deficits using a
purportedly ecologically valid measure i.e. the
TEA; and, moreover, to indicate that attentional
deficits may occur independently of executive dys-
function in people with schizophrenia.
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